Disruptive innovation to combat antimicrobial resistance

more

Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative new oligonucleotide-based antimicrobials. Our goal is to radically improve patient well-being and aid in the global fight against AMR.

Antimicrobial Resistance

science red blue vials

The world is running out of antimicrobial medicines. Antimicrobial resistance (AMR) is one of the most serious global healthcare threats affecting all ages and populations.

Find out more

Our Research

scientist vials

We are developing novel medicines that are active against resistant bacterial strains, have a controllable microbiological spectrum and are designed by a rapid and rational process.

Find out more

About Us

researcher

We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents.

Find out more